Enrique Rengifo Selected Research

G(M3) Ganglioside

1/2015	Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences.
1/2013	Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin.
1/2013	Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis.
1/2012	Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer.
1/2011	Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System.
1/2011	Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.
10/2004	Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enrique Rengifo Research Topics

Disease

6	Neoplasms (Cancer) 01/2015 - 10/2004
3	Melanoma (Melanoma, Malignant) 01/2011 - 04/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 01/2012
1	Lymphatic Metastasis 01/2013
1	Lymphoma (Lymphomas) 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Skin Neoplasms (Skin Cancer) 01/2011
1	Meningococcal Meningitis 04/2008
1	Vitiligo 04/2008

Drug/Important Bio-Agent (IBA)

7	G(M3) GangliosideIBA 01/2015 - 10/2004
4	GangliosidesIBA 01/2013 - 10/2004
3	Biological ProductsIBA 01/2015 - 01/2011
3	AntigensIBA 01/2013 - 10/2004
2	Monoclonal AntibodiesIBA 01/2011 - 10/2004
1	Epidermal Growth Factor (EGF)IBA 01/2015
1	GlycoconjugatesIBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	N-glycolylneuraminic acidIBA 01/2013
1	Heterophile AntigensIBA 01/2013
1	Cancer VaccinesIBA 04/2008
1	montanide ISA 51IBA 04/2008
1	VaccinesIBA 04/2008
1	Immunoglobulin FragmentsIBA 10/2004

Therapy/Procedure

3	Immunotherapy 01/2013 - 10/2004